NIBSC品牌简介 NIBSC 生物标准品- 品牌库 - 蚂蚁淘

来自 : 发布时间：2024-05-12

品牌简介:英国国家生物制品检定所 英国国家生物制品检定所(NIBSC) www.nibsc.ac.uk 国家生物标准委员会 (NBSB) 是隶属于英国政府的一家非部门公共机构 (NDPB)，它成立于 加入时间:2009-12-7 品牌\"NIBSC”产品分类 英国国家生物制品检定所 英国国家生物制品检定所(NIBSC) www.nibsc.ac.uk国家生物标准委员会 (NBSB) 是隶属于英国政府的一家非部门公共机构 (NDPB)，它成立于 1975 年，是《议会法案》的法定团体。 委员会通过对国家生物学标准与控制研究院 (NIBSC) 的管理，确保生物产品的质量与安全，从而保障并促进公众的健康。NIBSC提供对投入英国市场的生物药品的独立测试，尤其是用于英国儿童免疫计划的疫苗；它同时也是欧盟控制药品进入欧盟市场的官方药品控制实验室 (OMCL)。 如果出现不能满足药品存放要求或患者出现不良反应等问题，NIBSC 也可对已投入欧盟市场的产品进行检验。NBSB 认为对 NIBSC工作的核心职能制定并维护一项既均衡而又主次分明的计划至关重要。控制和评估生物药品。 开发和提供关键的生物学标准和其它参考资料。 开展针对任务的研究和开发工作。 NIBSC 战略目标：对有关生物产品的问题给出回复和建议； 提供生物药品方面的国家科技力量，维持满足科学和药物学领域新发展需求的灵活性、专业知识和设施； 作为化验方法（如量化生物学活性以及确定生物产品特征和进行安全评估）方面的国际领先权威机构运营并得到认同； 在欧洲生物产品的控制和标准化方面，继续发挥科学基础开发的中心作用； 在生物药品法规的科学方面帮助国际社会达成共识，并籍于此，与世界卫生组织紧密合作； 在控制和标准化的关键领域实现和维护质量鉴定。 生物药品控制药品中使用的生物物质包括病毒和细菌疫苗、从人类血液提取的产物、荷尔蒙以及其它储如细胞分裂素和生长素等治疗药物。这些生物物质对药物学和公众健康做出了巨大贡献并发挥着越来越大的作用，它们大大改善了全世界的疾病预防、诊断和治疗。生物药品是非常复杂的产品，正因为如此，大多数生物药品在投入使用前都会经过独立测试。 在英国和欧盟，生物产品在投入使用前会先提交到欧盟的其中一个 OMCL 进行测试。 确保疫苗的安全性尤其重要，因为它们将在全国范围内的免疫活动中用于大量健康的个人。通过研究院的测试和评估工作，NIBSC的科学家们帮助确保了生物产品的安全和有效性，同时也帮助缩短了将新产品投入临床使用的时间。 新产品，如最新一代复合疫苗，需要采取新颖的方法加以控制。 作为基因革命带来的影响之一，生物产品在数量和复杂程度上的潜在大幅增长也需要有更为彻底的控制战略方案。提供标准用于确保生物产品潜能的复杂化验要求使用生物学活性标准（有一批物质被指定了活性单位并用作\"基准”）。 世界卫生组织 (WHO) 国际标准系统提供了一组常用标准，它使得世界各地的质量测试结果具有可比性，也因此而重要非凡。 国际标准是\"金标准”，各国以及各生产商都可据此制定出自己的生物学测试标准。NIBSC 是目前世界上 WHO 国际标准和参考材料的主要制作人和分发人（提供 95％ 以上的标准）。 对疫苗、治疗中的大多数生物技术产品以及其它许多生物产品的有效使用都取决于 NIBSC 所提供的国际生物学标准的可用性。The National Biological Standards Board (NBSB) is a non-departmental public body (NDPB) of the UK government, established, in 1975, as a Statutory Body by Act of Parliament. The Board is responsible for safeguarding and advancing public health by assuring the quality and safety of biologicals, through its management of the National Institute for Biological Standards and Control (NIBSC).NIBSC provides independent testing of biological medicines for the UK market, in particular with vaccines for the UK children\'s vaccination programme, and operates as an Official Medicines Control Laboratory (OMCL) of the European Union for release of medicines onto the EU market. NIBSC testing of products already released onto the EU market may also be carried out when particular problems arise such as failure of storage conditions or following adverse reactions in patients.NBSB considers it essential to maintain a well balanced and clearly prioritised programme of work on the core functions of NIBSC\'s work.Control and evaluation of biological medicines. Development and provision of key biological standards and other reference materials. Mission-orientated research and development. NIBSC STRATEGIC AIMS:To respond to and advise on public health problems involving biologicals; To provide a national scientific capacity in the field of biological medicine, and to maintain the flexibility, expertise and facilities needed to address new developments in science and medicine; To operate, and be recognised, as a leading international authority on methods of assay such as those to quantify biological activity and to characterise and assess the safety of biologicals; To maintain a central role in the development of the scientific basis for control and standardisation of biologicals within Europe; To assist in the development of international consensus on scientific aspects of the regulation of biological medicines and, in this respect, work closely with the World Health Organisation; To achieve and maintain Quality Accreditation in key areas of control and standardisation. To read more about Biological standardization:A HISTORY OF BIOLOGICAL STANDARDIZATIONThe characterization and measurement of complex molecules important in clinical and research medicine. Contributions from the UK 1900-1995. What, why, how, where and by whom: A personal account by D.R. BanghamThis document is provided here with the permission of the Society of Endocrinology 公司名:NIBSC 英文名: 核心产品: 区域: 地址:广州大道北1521号恒隆大厦B座601室 联系人:陈锦 电话邮件联系方式:点击查看 总公司位于英国，公司保藏着世界各国优秀的生物标准品，广泛用于生物制药，为广大生物厂家带来较多的方便。WHO International Biological Reference PreparationsHeld and Distributed bv the WHO International Laboratories for Bioloaical StandardsPreparation StandardActivin A, human. Recombinant, Lyophilized. 5 units / ampoule. Alphafoetoprotein, human, Lyophilized. 100,000 IU / ampoule. Amikacin, Lyophilized. 50,600 IU / ampoule. Amphotericin B, Lyophilized. 940 IU / mg. Approximately 50mg of Amphotericin B.Ancrod, Lyophilized. 55 IU / ampoule. Anthrax spore vaccine, Lyophilized spore suspension of Bacillusanthracis strain 34 F2. 1 IU / ampoule.Anti-A blood typing serum, human, Lyophilized. 470 IU / ampoule.Anti-A blood typing serum, human, Lyophilized. 860 IU / ampoule.Anti-A blood typing serum, human, Lyophilized. 1,00 IU / ampoule of agglutinating; 1,000 IU / ampoule of complement-fixing activity.Anti-brucella ovis serum, Lyophilized. 1,000 IU / ampouleAnti-C complete blood-typing serum, human, Luman, Lyophilized. 100 IU / ampoule.Anti-c incomplete blood-typing serum, human, Luman, Lyophilized. 64 IU / ampoule.Anti-canine distemper serum, Lyophilized. 1,000 IU / ampoule.Anti-canine hepatitis serum, Lyophilized. 1,000 IU / ampoule.Anti-D (anti-Rh0) complete blood-typing serum, human, Lyophilized,128 IU / ampoule.Anti-D (anti-Rh0) complete blood-typing serum, human, Lyophilized,32 IU / ampoule.Anti-D immunoglobulin, human, Lyophilized. 300 IU (60 ug) / ampoule.Anti-double-stranded DNA serum, human, Lyophilized. 100 IU / ampoule.Anti-dysentery serum (Shiga), equine.Anti-E complete blood-typing serum, human, Lyophilized. 100 IU / ampoule.Anti-echinococcus serum, human, Lyophilized. 87.36 mg human serum/ ampoule.Anti-hepatitis A immunoglobulin, human, Lyophilized. 49 IU / ampoule.Anti-hepatitis B immunoglobulin, human, Lyophilized. 50 IU / ampoule.Anti-hepatitis E serum, human, Lyophilized. 50 units / ampoule.Anti-human platelet antigen-1a, Lyophilized. No unitage assigned.Anti-interferon alpha serum, human, Lyophilized. 8,000 neutralisingunits / ampoule.Anti-interferon beta serum, human, Lyophilized. 1,500 neutralising units/ ampoule.Anti-measles serum. Human, Lyophilized. 5 IU / ampoule.Anti-mycoplasma gallisepticum serum, Lyophilized. 1,000 IU / ampouleof agglutinating activity and 1,000 IU / ampoule of haemagglutination-inhibiting activity.Anti-newcastle-disase serum, Lyophilized, 320 IU / ampoule.Anti-nuclear ribonucleoprotein serum, Lyophilized. No unitage assigned.Anti-nuclear-factor (homogeneous) serum, Lyophilized. 100 IU / AmpouleAnti-parvovirus B 19 (IgG) serum, Lyophilized. 100 IU / ampoule.Anti-pertussis serum, mouse.Anti-poliovirus serum (Types 1, 2, 3,), Lyophilized. 25 IU / ampoule(Type 1), 50 IU / ampoule (Type 2), 5 IU / ampoule (Type 3).Anti-Q-fever serum, bovine, Lyophilized. 1,000 IU / ampoule.Anti-rabies immunoglobulin, human, Lyophilized. 30 / ampoule.Anti-rubella immunoglobulin, human, Lyophilized. 1,600 IU / vial.Anti-salmonella pullorum serum (Standard Form S), Lyophilized. 1,000IU / ampoule.Anti-salmonella pullorum serum (Variant Form V), Lyophilized. 1,000 IU / ampoule.Anti-smooth muscle serum, Lyophilized. No unitage assigned.Anti-staphylococcal P-V leucocidin serum, equine, Lyophilized, 150 IU /ampoule.Anti-swine fever serum, Lyophilized. 1,000 IU / ampoule.Anti-syphilitic serum, human, Lyophilized. 49 IU / ampoule.Anti-tetanus immunoglobulin, human, Lyophilized. 120 IU / ampoule.Anti-tetanus serum, equine, Lyophilized. 1,400 IU / ampoule.Anti-thrombin, concentrate, human, Lyophilized. Functional potency-4.7IU / AMPOULE. Antigenic potency – 5.1 IU / ampoule.Anti-thrombin, plasma, human, Lyophilized. 0.85 IU / ampoule.Anti-thyroglobulin serum, human, Lyophilized. 1,000 IU / ampoule.Anti-tick borne encephalitis serum (louping ill (Moredun) virus),Lyophilized. No unitage assigned.Anti-tick borne encephalitis serum (Russian spring-summer (sophynand absettarov) virus), Lyophilized. No unitage assigned.Anit-toxoplasma serum (lgG), human, Lyophilized. 20 IU / ampoule.Anti-toxoplasma serum, Lyophilized. 1,000 IU / ampoule.Anti-typhoid serum, equine, Lyophilized. 5 ml of freeze dried horseserum per ampoule.Anti-varicella zoster immunoglobulin, human, Lyophilized. 50 IU /ampoule.Anti-yollow fever serum, monkey, Lyophilized. 143 IU / ampoule.Apolipoprotein A-1, Lyophilized. 1.66mg / vial.Apolipoprotein B. Frozen. 1.22g / l. Vials. 1 ml.Arginine vasopressin, Lyophilized. 8.2 IU / ampoule.Atrial natriuretic factor, human, Lyophilized. 2.5 IU / ampoule.Bacitracin, Lyophilized. Approximately 100mg of zinc bacitracin (74 IU/ mg)Basic fibroblast growth factor (bFGF, FGF-2), Lyophilized. 1,600 IU/ampoule.BCG vaccine, Lyophilized. 2.5mg of semi-dry bacillary mass / 5-mlampoule.Beta-2 microglobulin, Lyophilized. 100 IU / ampoule.Beta-thromboglobulin, human, Lyophilized. 500 IU / ampoule.Birch pollen extract (Betula verrucosa), Lyophilized. 100,000 IU / ampoule.Bleomycin complex A2/B2, Lyophilized. 8.910 IU / ampoule.Blood coagulation factor IX concentrate, human, Lyophilized. 10.7 IU/ vial.Blood coagulation factor IXa, concentrate, human, Lyophilized. 11.0IU/ ampoule.Blood coagulation factor VII concentrate, human, Lyophilized. 6.3 IU/ ampoule.Blood coagulation factor VIIa concentrate, human, Lyophilized. 5,130 IU/ ampoule.Blood coagulation factor VIII and von Willebrand factor, plasma, human, Lyophilized. 0.68 IU / ampoule Factor VIII;C; 0.94 IU / ampoule factorVIII, Antigen; 0.91 IU / ampoule VWF: antigen; 0.78 IU / ampouleVWF: ristocetin cofactor; 0.94 IU / ampoule VWF: collagen bindingBlood coagulation factor VIII concentrate, human, Lyophilized. 11.0 IU /ampoule.Blood coagulation factors II, VII, IX, X, plasma, human, Lyophilized.0.91 IU / (factor II), 1.00 IU (factor VII), 0.86 IU (factor IX), 0.93 IU(factor X) / ampoule.Blood coagulation factors II, and, X concentrate, human, Lyophilized.11.2 IU / (factor II), 10.2 IU (factor X) / ampoule.Bone morphogenic protein-2, Lyophilized. 5,000 units / ampoule.Brain drived neurotrophic factor, Lyophilized. 16,000 units / ampouleCalcitonin, eel, Lyophilized. 88 IU / ampoule.Calcitonin, human, Lyophilized. 1705 IU / ampouleCalcitonin, porcine, Lyophilized. 0.8 IU / ampoule.Calcitonin, salmon, Lyophilized. 138 IU / ampoule.Capreomyin, Lyophilized. 920 IU / mg, Approximately 80mg ofcapreomycin sulfate.Carcinoembryonic antigen (CEA), human, Lyophilized. 100 IU / ampoule.Chlortetracycline, Lyophilized. 1,000 IU / mg, Approximately 75 mg ofchlortetracycline hydrochloride.Cholera antitoxin, goat, Lyophilized. 2,200 IU / ampoule.Cholera vaccine (Inaba), Lyophilized. 40,000,000,000 organisms /ampoule.Cholera vaccine (Ogawa), Lyophilized. 40,000,000,000 organisms /ampoule.Chorionic gonadotrophin, alpha subunit, human, for immunoassay,Lyophilized. 70 IU / ampoule.Chorionic gonadotrophin,beta subunit, human, for immunoassay,Lyophilized. 70 IU / ampoule.Chorionic gonadotrophin, human, Lyophilized. 650 IU / ampoule.Ciliary Neurotrophic Factor for the bioassay of human CNTF,Lyophilized. For bioassay: 8,000 units / ampoule, for immunoassay: 6.5ug / ampoule.Clostridium botulinum Type B antitoxin, equine, Lyphilized. 30.7 IU /ampoule.Clostridium botulinum Type B antitoxin, equine, Lyphilized. 1,000 IU /ampoule.Clostridium novyi alpha toxoid, Lyophilized. No unitage assigned.Clostridium perfringens beta antitoxin, equine, Lyophilized. 4,770 IU /ampoule.Clostridium perfringens beta toxoid, Lyophilized. No unitage assigned.Clostridium perfringens epsilin antitoxin, equine, Lyophilized. 1,020 IU /ampoule.Clostridium perfingens epsilon toxoid, Lyophilized. No unitage assigned.Colistin methane sulfonate, Lyophilized. 12,700 IU / mg, Approximately75mg of colistin methane sulfonate.Colistin, Lyophilized. 20,500 IU / mg, Approximatley 75mg of colistinSulfate.Corticotrophin (ACTH), porcine, Lyophilized. 5 IU / ampoule.C-reactive protein, human, Lyophilized. 0.049 IU / ampoule.Dihydrostreptomycin, Lyophilized. 820 IU / mg, Approximately 200mgof dihydrostreptomycin sulfate.Diphtheria (schick) test toxin, Lyophilized. 900 IU / ampoule.Diphtheria antitoxin, equine, Lyophilized. Bottles in the form of 10 ml of a solution of dried serum in 66% v/v of glycerol. 10 IU / ml.Diphtheria toxoid, adsorbed, Lyophilized. 160 IU / ampoule.Diphtheria toxoid, for flocculation tests, Lyophilized. 900 Lf IU / ampoule.Dog hair and dander extract (Canis domesticus). Lyophilized. 100.000IU / ampoule.Elcatonin, Lyophilized. 15 IU / ampoule.Endotoxin for Limulus Amoebocyte Lysate (LAL) gelation tests,Lyophilized. 10,000 IU / ampoule.Epidermal growth factor (1-52), human, recombinant, Lyophilized. 1.75ug / ampoule. No unitage assigned.Epidermal growth factor , human, recombinant, Lyophilized. 2,000 IU/assigned.Erythromycin, Lyophilized, 920 IU / mg, Approximately 75 mg of erythromycin A base.Erythropoietin, human, urinary, Lyophilized. 10 IU / ampoule.Erythropoietin, rDNA-derived, Lyophilized. 86 IU / ampoule.Ferritin, human, recombinant, Lyophilized. 6.3 ug / ampoule.Fibrinogen concentrate human, Lyophilized. Total protein 15 mg /ampoule. Clottable protein 10.5mg / ampoule.Fibrinogen, plasma, human, Lyophilized. 2.2 mg / ampoule.FMS-like tyrosine kinase 3 ligand, Lyophilized. 1,000 units / ampoule.Follicle stimulating hormone, human, recombinant, for bioassay,Lyophilized, 138 IU / ampoule.Follicle stimulating hormone, human, pituitary, Lyophilized. 80 IU / ampoule.Follicle stimulating hormone, human, recombinant for immunoassay, Lyophillzed. 60 IU / ampoule.Follicle stimulating hormone, human, urinary (Urofollitropin), for Bioassay, Lyophilized. 121 IU / ampoule.Follicle-stimulating hormone and luteinising hormone human, urinary for bioassay, Lyophilized. FSH 72 IU / ampoule.LH 70 IU / ampoule.Gas-gangrene antitoxin (Clostridium histolyticum), equine, Lyophilized.50 IU / ampoule.Gas-gangrene antitoxin (Clostridium histolyticum), equine, Lyophilized.270 IU / ampoule.Gas-gangrene antitoxin (Clostridium sordellii), equine, Liquid. 7,500 IU/ampoule Bottles in the form of 10ml of a solution of dried serum in 66% v/v of glycerol. 20 IU / ml.Gas-gangrene antitoxin, (Clostridium septicum), equine, Lyophilized.500 IU / ampoule.Gentamicin, Lyophilized. 31,020 IU / ampoule. Glucagons, porcine, lyophilized. 1,49 IU / ampoule.Gonadotrophin, equine serum, Lyophilized. 1,600 IU / ampoule.Gramicidin, Lyophilized. 1,000 IU / mg. Approximately 55 mg of gramicidin.Granulocyte colony stimulating factor, human, recombinant, Lyophilized. 10,000 IU / ampoule.Granulocyte-macrophage colony stimulating factor, human,recombinant, Lyophilized. 10,000 IU / ampoule.Haemoglobin A2, raised, Lyophilized. 5.3% (w/w) of total haemoglobin.Haemoglobin F, raised, Lyophilized. 3.4% (w/w) of total haemoglobin.Haemoglobincyanide, liquid. 49.79 umol / 1.Heparin, low molecular weight (calibrant for molecular weight distribution),Lyophilized. No unitage assigned.Heparin, low molecular weight, Liquid. 1097 IU / ampoule (anti-Xa), 326IU / ampoule (anti-lla).Heparin, unfractionated, Lyophilized. 2,031 IU / ampoule.Hepatitis A RNA, Lyophilized. 50000 IU / vial.Hepatitis A vaccine, inactivated, Frozen. 100 IU / ml of immunogenicactivity; 100 IU / ml of antgen content.Hepatitis B surface antigen, subtype adw2, genotype A, Lyophilized. 33IU / vial.Hepatitis B surface antigen, subtype adw2, genotype A, Lyophilized. Dilutonal panel (IU / vial: 8.25: 2.06; 0.52; 0.13)Hepatitis B vaccine, plasma derived, for immunogeniciy studies, Liquid.1.2 ml / ampoule. 20ug Hepatitis B surface antigen / ml.Hepatitis B virus DNA, Lyophilized. 500.000 IU / vial.Hepatitis C virus DNA, Lyophilized. 500.000 IU / vial.Hepatocyte growth factor/scatter factor (precursor), human, Lyophilized.2.000 IU / ampoule.Hepatocyte growth factor/scatter factor , human, Lyophilized.4.000 IU /ampoule.HIV-1 p24 antigen, Lyophilized. 1,000 IU / ampoule.HIV-1 RNA, Lyophilized. 100.000 IU / vial.Horseradish peroxidase-conjugated sheep anti-human 1gG(H and Lchains), Lyophilized. No unitage assigned.House-dust mite extract (Dermatophagoides pteronyssinus),Lyophilized. 10.000 IU / ampoule.Human antibody against Haman platelet 5B antigen.Human Chorionic Gonadotrophin for immunoassay of intact hCG,Lyophilized, 1.88 nmol / ampoule.Human Chorionic Gonadotrophin for immunoassay of alpha subunithCG (hCG-alpha), Lyophilized. 0.84 nmlo / ampoule.Human Chorionic Gonadotrophin for immunoassay of beta coreFragment hCG (hCG-beta-cf), Lyophilized. 1.02 nmol / ampoule.Human Chorionic Gonadotrophin for immunoassay of hCG beta subunit (hCG-beta), Lyophilized. 0.88 nmol/ampouleHuman Chorionic Gonadotrophin for immunoassay of nicked hCG(hCG-n), Lyophilized. 0.78 nmol/ampouleHuman Chorionic Gonadotrophin for immunoassay of nicked hCG betaSubunit (hCG-beta-n), Lyophilized. 0.33 nmol/ampoule 1st Reference Reagent 19981st International Standard 19751st International Standard 19831st International Standard 19631st International Reference Preparation 19761st International Reference Preparation 19782nd International Standard 19813rd International Standard 19812nd International Standard 19751st International Standard 19851st International Standard 19841st International Standard 19761st International Standard 1967 1st International Standard 19671st International Standard 19901st International Standard 19661st International Reference Preparation 19771st International Standard 19851st International Standard 1928 1st International Standard 1983 1st International Reference Reagent 1975 2nd International Standard 1998 1st International Reference Reagent 1977 1st Reference Reagent 19971st Reference Reagent 1997 1st International Reference Reagent 1994 1st International Reference Reagent 1994 2nd International Standard 19901st International Reference Preparation 19691st International Reference Preparation 19681st International Reference Preparation 19831st International Reference Preparation 19701st International Standard 19951st Reference Reagent 19992nd International Standard 19911st International Standard 19541st International Standard 19931st International Standard 19961st International Standard 19931st International Standard 19731st International Reference Reagent 19831st International Standard 19651st International Standard 19631st International Standard 19581st International Standard 19922nd International Standard 19692nd International Standard 19972nd International Standard 19941st International Reference Preparation 19781st International Reference Preparation 19641st International Reference Preparation 19641st International Standard 20033rd International Standard 19941st International Reference Preparation 19571st International Standard 19871st International Standard 19621st International Reference Reagent 19921st International Reference Reagent 19931st International Standard 19781st International Standard 19872nd International Standard 19641st International Standard 19931st International Reference Preparation 19651st International Standard 19851st International Standard 19841st International Standard 19861st International Reference Preparation 19803rd International Standard 19961st International Standard 19991st International Standard 19981st International Standard 19935th International Standard 20037th International Standard 20033rd International Standard 20013rd International Standard 19991st Reference Reagent 19971st Reference Reagent 19971st International Standard 19892nd International Standard 19912nd International Standard 19913rd International Standard 19991st International Reference Preparation 19671st International Reference Preparation 19752nd International Standard 19691st International Standard 19842nd International Reference Preparation 19712nd International Reference Preparation 19711st International Reference Preparation 19741st International Reference Preparation 19744th International Standard 19991st Reference Reagent 20012nd International Standard 19851st International Standard 19621st International Reference Preparation 19662nd International Standard 19981st International Reference Preparation 19752nd International Standard 19851st International Reference Preparation 19751st International Reference Preparation 19681st International Standard 19683rd International Standard 19621st International Standard 19862nd International Standard 19661st International Standard 19541st International Standard 19343rd International Standard 19991st International Reference Reagent 19881st International standard 19861st International standard 19862nd International Standard 19961st International Reference Reagent 19941st International standard 19942nd International Standard 19782nd International Reference Preparation 19701st International Standard 19903rd International Standard 19961st International Standard 20002nd International Standard 19991st Reference Reagent 19971st International Standard 19951st International Standard 19861st International Standard 19971st International Standard 19954th International Standard 20003rd International Standard 19715th International Standard 19621st International Standard 19383rd International Standard 19662nd International Standard 19951st International Standard 19732nd International Standard 19661st International Reference Reagent 19661st International Standard 19921st International Standard 19921st International Reference Reagent 19931st International Reference Reagent 19936th International Standard 19981st International Reference Reagent 19932nd International Standard 20035th International Standard 19981st International Standard 20031st International Standard 19992nd International Standard 20031st International Reference Reagent 19861st International Standard 19991st International Standard 19971st International Standard 19991st International Standard 19991st International Reference Reagent 19921st International Standard 19991st International Reference Preparation 19821st International Standard 19831st Reference Reagent 20011st Reference Reagent 20011st Reference Reagent 20011st Reference Reagent 20011st Reference Reagent 20011st Reference Reagent 2001Human growth hormone, pituitary, Lyophilized. 4.4 IU / ampoule.Human serum complement components C1q, C4, C5, factor B, andwhole functional complement CH50, Lyophilized. C1q: 100 IU / ampoule, C4: 100 IU / ampoule, Factor B: 100 IU / ampoule, Wholefunctional complement CH50: 100 IU / ampoule.Human serum immunoglobulin E, Lyophilized. 5,000 IU / ampoule.Human serum immunoglobulins G, A, and M (lgG, lgA ang lgM),Lyophilized. 100 IU lgG, 100 IU lgA ang 100 IU lgM / ampoule.Human serum proteins, for immunoassay: albumin; alpha-1-antitrypsin;Alpha-2-macroglobulin; ceruloplasmin; complement C3; transferring,Lyophilized, 100 IU of each protein / ampoule.lnhibin A, human, recombinant, Lyophilized. 150,000 IU / ampoule.Inhibin B Lyophilized. Lmmunoassay calibration 12ng / ampoule.Bioactivity: 12 units / ampoule.Inhibin, porcine, Lyophilized. 2,000 IU / ampoule.Insulin C-peptide, human, Lyophilized. 10ug / ampoule.Insulin, bovine, Hydrated crystals. 25.7 IU / mg. Approximately 50 mg /ampoule.Insulin, human, for immunoassay, Lyophilized. 3 IU / ampoule.Insulin, human, Hydrated crystals. 26 IU / mg. Approximately 50mg /ampoule.Insulin, porcine, Hydrated crystals. 26 IU / mg. Approximately 50mg /ampoule.Insulin-like growth factor 1 for bioassay, Lyophilized. 150 IU / ampoule.Insulin-like growth factor I for immunoassay,lyophilized.3.1ug/ampoule.Insulin-like growth factor II, human, recombinant ,Lyophilized.5,000units/ampoule.Interferon alpha, human , leukocyte N3, Lyophilized .60,000IU/Ampoule.Interferon alpha1/8,human, Lyophilized.27,000IU/ampouleInterferon alpha 2c , human, recombinant , Lyophilized.40,000IU/Ampoule.Interferon alpha consensus,human, recombinant , Lyophilized.100,000IU/ampouleInterferon alpha, human, leukocyte (HulFN-a(Le)),Lyophilized.11,000IU/ampoule.Interferon alpha ,human , lymphobiastoid N1 (HuiFN-alpha(Ly)).Lyophilized. 38,000IU/ampoule.Interferon alpha-1 (alpha-D),human,recombinant,(rHuIFN-alpha1(alphad)). Lyophilized.8,000IU/ampouleInterferon alpha2a. human, recombinant (rHuIFN-alpha2(alpha-A)),Lyophilized.63,000IU/ampoule.Interferon alpha2b ,human, recombinant, (rHuIFN-alpha2(alpha-2b)),Lyophilized. 70,000IU/ampouleInterferon beta ser – 17 , human , recombinant (rHuIFN-beta (ser-17)),Lyophilized. 6,000IU/ampoule.Interferon beta , human , fibroblast (HuIFN-beta), Lyophilized.4,000IU/Ampoule.Interferon gamma, human , recombinant , Lyophilized. 80,000IU/Ampoule.Interferon omega, human , recombinant,Interferon,chick, Lyophilized. 80IU/ampoule.Interferon , murine, alpha (MuIFN-alpha),Lyophilized. 16,000IU/ampoule.Interferon,murene,beta (MuIFN-beta ), Lyophilized. 15,000IU/ampouleInterferon, murine, gamma (MuIFN-gamma), Lyophilized 1,000IU/Ampoule.Interferon , rabbit , Lyophilized. 10,000IU/ampouleInterleukin-1 alpha, human , Lyophilized. 117,000IU/ampoule.Interleukin-1 beta , human, Lyophilized. 100,000IU/ampoule.Interleukin-10. human, Lyophilized. 5,000units/ ampoule.Interleukin-11 human, Lyophilized . 5,000units /ampouleInterleukin-12,human, Lyophilized. 10,000 units /ampouleInterleukin-13 , human, Lyophilized. 1,000 units /ampoule.Interleukin-15 , human, Lyophilized. 1,0000 units /ampoule.Interleukin-2 , human, Lyophilized. 1,00 IU /ampoule.Interleukin-3 , human, Lyophilized. 1,700 IU /ampoule.Interleukin-4 , human, Lyophilized. 1,000 IU /ampoule.Interleukin-5, human, Lyophilized. 5,000 units /ampoule.Interleukin-6 , human, Lyophilized. 100,000 IU /ampoule.Interleukin-7 , human, Lyophilized. 100,000 units /ampoule.Interleukin-8, human, Lyophilized. 1,000 IU /ampoule.Interleukin-9 , human, Lyophilized. 1,000 units /ampoule.Islet cell antibodies , Lyophilized. 20 units /ampoule of islet cellAntibodies; 100units/ampoule of anti-GAD65;100units/ampouleOf anti-IA-2Kanamycin,Lyophilized. 10,345IU/ampouleKininogenase, porcine, pancreatic,Lyophilized.22.5 IU/ampouleLeptin,human, Lyophilized. 4,000 IU/ampouleLeptin,mouse, Lyophilized. 4,000 IU/ampouleLeukaemia inhibitory factor, Lyophilized. 10,000units/ampouleLipoprotein (a) Loyphilized 0.107 nanomoles/vialLuteinizing hormone , bobine, for immunoassay,Lyophilized. 0.025 IU/ampouleLuteinizing hormone, human,pituitary, alpha subunit,Lyophilized 10IU/ampoule.Luteinizing hormone, human,pituitary, beta subunit,Lyophilized 10IU/ampoule.Luteinizing hormone, human,pituitary, Lyophilized 35 IU/ampoule.Lymecycline,Lyophilized. 948 IU/mg Approximately 100mg.Lysine vasopressin, Lyophilized. 7.7 IU/ampoule.Macrophage colony stimulating factor. Human, recombinant,Lyophilized. 60,000IU/ampouleMAPREC analyses of poliovirus type 3 (Sabin).Lyophililzed . 0.9%472-CNucleotide/vial.MAPREC analyses of poliovirus type 3 (Sabin),low virus referenceLyophililzed . 0.7%472-C Nucleotide/vial.Measles vaccine (live),Lyophilized. 4.3log 10(20000)infectious units/vialMethacycline,Lyophoilized. 924 IU/mg . Approximately 50mg of Methacycline hydrochlolride.Mumps vaccine (live),Lyohilized. 4.6 log 10(40000)infectious units/vialNeomycin B,Lyophilized. 670 IU/mg . Ampoules containing Approximately 25mg of neomycin B sulfate.Neomycin,Lyophilized. 775 IU/mg Ampoules containingApproximately 50mg of neomycin B sulfate.Nerve growth factor, Lyophilized. 10,000units / ampouleNetilmicin, Lyophilized 4.810 IU/ampouleNewcastle (Hitchner B 1 strain )disease vaccine , live Lyophilized.NoUnitage assigned.Newcastle disease vaccine (inactivated), Lyophilized . 525 IU/ampoule.Novobiocin,Lyophilized 970 IU/mg Approximately 100mg of Novobiocin acid.Nystatin , Lyophilized 4,855IU/mg , Approximately 100mg Oncostatin M lyophilized . 25,000units /ampouleOpacity,Oxytocin, lyophilized 12.5 IU /ampoule Parathyroid hormone , bovine, lyophilized , 39 IU/ ampoule Parathyroid hormone , human , for immunoassay , lyophilized ,0.1 IU/Ampoule Paromamycin.Parvovirus B 19 DNA human , lyophilized . 500,000 IU / ampouliPertussis Toxin, Lipuid. 10000 IU/ampoulePertiussis vaccine, lyophilized 46 IU / ampoule Placental lactogen, human , for immunoassay, lyophilized 0.000850 IU/ampoulePlasmin, human , lyophilized 5.3 IU / ampoulePlasminogen-activator inhibitor 1 (PAI-1),human , lyophilized, Tissue-Plasminogen-activator 27.5 IU of neutralizing activiy / ampoule. Urinary-Plasminogen-activator 7 IU of neutralizing activity/ampoulePlatelet derived growth factor –Bbisoform, lyophilized , 3,000 IU/ampoulePlatelet foctor 4 , Lyophilized. 400IU/ampoulePoliomyelitis vaccine (inactivated),lyophilized. Type 1 antigen. 430 D-Antigen units / ml , Type 2 antigen :95 D- antigen unts /ml Type3Antigen : 285 D-antigen units / ml.Poliovirus (Sabin)live attenuated. Lyophilized. Type1:66 log 10CCID50/ml ; Type 2:5.6log 10CCID50 / ml ; Type 3:6.2 log10CCID50 Polymyxin B. 1st International Standard 19821st International Reference Preparation 19802nd International Reference Preparation 19801st International Reference Preparation 19701st International Reference Preparation 19771st International Standard 19941st Reference Reagent 20001st International Standard 19901st International Reference Reagent 19861st International Standard 19861st International Reference Reagent 19741st International Standard 19861st International Standard 19861st International Standard 1994l st Reference Reagent 2000lst Reference Reagent 1999lst intemational Standard 1999lst intemational Standard 1999lst intemational Standard 1999lst intemational Standard 19992 nd intemational Standard 19992 nd intemational Standard 1999lst intemational Standard 19992 nd intemational Standard 19992 nd intemational Standard 1999l st international Reference Reagent 19873 rd international Standard2003l st intemational Standard 1994l st intemational Standard 1999l st international Reference Reagent 19872 nd intemational Standard 19872 nd intemational Standard 1987l st international Reference Reagent 1987l st intemational Standard 1978l st intemational Standard 1989l st intemational Standard 1989l st Reference Reagent 1997l st Reference Reagent 1996l st Reference Reagent 1996l st Reference Reagent 1996l st Reference Reagent 1996l st international Standard1987l st international Standard1994l st international Standard1994l st Reference Reagent 1996l st international Standard1992l st Reference Reagent 1996l st international Standard1995l st Reference Reagent 1996l st Reference Reagent 1999l st international Standard1986l st international Standard1982l st international Standard1999l st international Standard1999l st Reference Reagent 1996l st Reference Reagent 2003l st international Standard1985l st international Standard1984l st international Standard19842 nd intemational Standard 19882 nd international Reference preparation1971l st international Standard1978l st international Standard1992l st international Standard1997l st international Standard1996l st international Standard19972 nd intemational Reference Reagent 1994l st international Reference preparation1969l st intemational Reference Reagent 1994l st international Reference preparation19752 nd international Reference preparation1975l st Reference Reagent 1996l st international Standard1989l st international Reference preparation1967l st international Standard1963l st international Standard19652 nd international Standard1982l st Reference Reagent 19965 th international Standard19754 th international Standard1978l st international Standard1985l st international Reference preparation1981l st international Reference preparation1996l st international Standard2000l st international Standard20033 st international Standard1998l st international Reference preparation19773 st international Standard1998l st international Standard1995l st international Standard 1997l st international Standard1984l st intemational Reference Reagent 1994l st intemational Reference Reagent 19952 nd intemational Standard 1969